A comprehensive Certificate of Analysis (COA) supported by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) is essential for confirming the structural integrity and purity of research-grade Tesamorelin. This technical guide outlines analytical parameters, chromatographic interpretation, and quality control protocols required for reproducible in vitro and preclinical experimentation.
A comprehensive Certificate of Analysis (COA) supported by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) is essential for confirming the structural integrity and purity of research-grade Tesamorelin. This technical guide outlines analytical parameters, chromatographic interpretation, and quality control protocols required for reproducible in vitro and preclinical experimentation.
A Tesamorelin COA HPLC is an official analytical document confirming the chemical purity, structural identity, and bioburden profile of synthesized Tesamorelin for laboratory research. Utilizing reverse-phase high-performance liquid chromatography (RP-HPLC) paired with mass spectrometry (MS), the COA provides quantitative evidence that the research peptide meets strict purity thresholds—typically ≥98%—free from truncated peptide sequences, residual solvents, or heavy metal contamination.
For investigators sourcing compounds through our catalog of research peptides, obtaining a lot-specific COA is the primary benchmark for experimental reproducibility. Unverified or impure peptides introduce non-quantifiable variables into cell culture assays and animal models, compromising data integrity.
Tesamorelin is a synthetic N-hexenoyl analog of human growth-hormone-releasing hormone (GHRH). Structurally comprised of 44 amino acids, it features a trans-3-hexenoic acid group attached to the N-terminal tyrosine residue. This specific modification stabilizes the peptide backbone against rapid enzymatic cleavage by dipeptidyl peptidase-IV (DPP-IV), extending its biological half-life in physiological media compared to native GHRH(1-44).
The molecular formula of Tesamorelin is C221H366N72O67S, with a calculated theoretical monoisotopic mass of approximately 5135.86 Da. Laboratory researchers evaluating Tesamorelin 10mg must verify that analytical testing matches this target mass precisely, as minor deletions or side-chain modifications can drastically alter receptor binding kinetics.
In preclinical studies, Tesamorelin functions as a potent, selective growth-hormone-releasing hormone receptor (GHRHR) agonist. By binding to GHRH receptors located on pituitary somatotropes, it stimulates the synthesis and pulsatile secretion of endogenous growth hormone (GH). In turn, GH activity signals the hepatic synthesis of insulin-like growth factor 1 (IGF-1).
In vitro assays and rodent models demonstrate that Tesamorelin-mediated GHRHR activation regulates downstream metabolic pathways. Research indicates its involvement in lipolysis, hepatic lipid oxidation, and nitrogen retention. Because of these distinct pathways, scientists utilize Tesamorelin to investigate metabolic regulation, visceral adipose tissue reduction mechanisms, and cellular repair processes in controlled laboratory environments. Broader technical discussions on secretagogue pathways are detailed in our research library hub.
Reverse-phase high-performance liquid chromatography (RP-HPLC) is the gold standard for quantifying the chemical purity of synthetic peptides. The technique separates molecules based on hydrophobic interactions with a stationary phase (typically a C8 or C18 silica column) under a liquid mobile phase gradient comprising water, acetonitrile, and trifluoroacetic acid (TFA).
When analyzing a Tesamorelin HPLC chromatogram, the target peptide presents as a major sharp peak at a defined retention time (Rt). The area under the curve (AUC) of this principal peak relative to total integrated peak area determines the overall percentage purity. A high-grade research lot yields an AUC of 98% or greater. Minor secondary peaks represent synthesis deletion sequences, failure sequences, or oxidation products. Examining peak symmetry and baseline resolution ensures that co-eluting impurities are not masked during detection.
While RP-HPLC establishes chemical purity, mass spectrometry (MS) confirms molecular identity. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) spectrometry measures the mass-to-charge ratio (m/z) of the ionized peptide.
Because Tesamorelin has a molecular weight exceeding 5 kDa, ESI-MS typically yields multiple charge states ([M+4H]4+, [M+5H]5+, [M+6H]6+). Deconvolution algorithms compute the exact observed molecular mass from these charge distributions. A passing mass spectrum must show an observed mass within ±1 Da of the theoretical molecular weight (5135.86 Da). Matching both HPLC retention profiles and ESI-MS spectra confirms that the target peptide is correctly synthesized without truncation or unexpected amino acid substitutions.
Endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are common contaminants in biological preparations. In cellular models and animal assays, trace endotoxin levels can trigger unintended inflammatory responses via Toll-like receptor 4 (TLR4) signaling, distorting cytokine profiles and confounding experimental results.
Quality testing for Tesamorelin includes quantitative Limulus Amebocyte Lysate (LAL) testing or recombinant Factor C (rFC) assays. Research-grade compounds must display endotoxin concentrations below strictly defined thresholds, typically <0.1 EU/mg or <5.0 EU/mg depending on the intended in vitro or in vivo model system. Verification of low endotoxin levels on the COA ensures that physiological responses observed during experimentation stem purely from peptide activity rather than immune activation.
To contextualize experimental designs, investigators frequently compare Tesamorelin against other peptide compounds targeting the GHRH receptor axis. While all share a core mechanism of stimulating pituitary somatotropes, structural modifications alter their stability, binding affinities, and clearance rates.
For instance, CJC-1295 No DAC (a 29-amino acid tetrasubstituted GHRH fragment) and Sermorelin (the truncated 29-amino acid sequence of GHRH) exhibit shorter or modified plasma persistence profiles compared to the N-terminally modified 44-amino acid structure of Tesamorelin. Furthermore, studies combining GHRH analogs with selective growth hormone secretagogue receptor (GHSR) agonists like Ipamorelin demonstrate synergistic GH release dynamics in preclinical rodent models. Comparing lot-specific HPLC profiles across these distinct sequences ensures precise molar equivalence in comparative assays. Additional details on sequence selection can be explored in our review of GHRH and GHRP research peptides.
Lyophilized Tesamorelin is highly stable when stored at -20°C or -80°C in a desiccated environment, shielded from light exposure. Before opening, vials should be allowed to equilibrate to room temperature to prevent atmospheric moisture condensation on the cake.
For laboratory reconstitution, researchers utilize sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS), depending on assay parameters. Gentle swirl rotation should be applied; high-shear mechanical agitation or vortexing must be avoided to prevent peptide aggregation or surface denaturation. Reconstituted aliquots should be held at 2°C to 8°C for short-term handling or sub-aliquoted and stored at -80°C to avoid repeated freeze-thaw cycles. Detailed protocols for preparation are archived in our research documentation.
PX1 Research enforces strict quality control standards for every production batch. All compounds are manufactured in USA-based, ISO 17025 accredited, and GMP-compliant facilities. Every lot of Tesamorelin undergoes rigorous independent third-party analytical verification, ensuring uncompromised purity and structural precision.
We supply lot-traceable documentation containing full RP-HPLC chromatograms, mass spectra, and endotoxin assay results. Orders placed by academic institutions and private research facilities ship same-day (Monday–Friday) from our California and Arizona logistics hubs. Principal investigators requiring bulk quantities or dedicated lot reservations can establish customized supply pipelines through our wholesale lab accounts.
What is the minimum HPLC purity threshold for research-grade Tesamorelin?
PX1 Research requires a minimum RP-HPLC purity threshold of ≥98% for research-grade Tesamorelin. This ensures that experimental findings are free from artifacts caused by synthesis failure sequences or degradation contaminants.
How does mass spectrometry verify Tesamorelin identity on a COA?
Mass spectrometry (ESI-MS or MALDI-TOF) measures the precise molecular weight of the peptide. For Tesamorelin, the observed monoisotopic or deconvoluted average mass must match the theoretical molecular weight of 5135.86 Da within a ±1 Da margin.
Why is endotoxin testing critical for Tesamorelin used in cell culture or animal research?
Bacterial endotoxins (LPS) trigger inflammatory signaling via TLR4 pathways in immune and parenchymal cells. Low endotoxin levels (<0.1 EU/mg) ensure that observed cellular responses are driven by GHRH receptor activity rather than inflammatory contamination.
What solvent gradients are typically used in RP-HPLC for Tesamorelin analysis?
RP-HPLC testing for Tesamorelin commonly employs a C18 reverse-phase column with a linear gradient of Mobile Phase A (0.1% TFA in water) and Mobile Phase B (0.1% TFA in acetonitrile) monitored at UV wavelengths of 214 nm or 220 nm.
How should lyophilized Tesamorelin be stored upon receipt in the lab?
Lyophilized Tesamorelin should be stored at -20°C or -80°C in a dry, dark environment. To prevent degradation, avoid exposing the unsealed vial to ambient humidity prior to temperature equilibration.
Can Tesamorelin undergo repeated freeze-thaw cycles after reconstitution?
No. Repeated freeze-thaw cycles induce peptide denaturation, aggregation, and loss of functional activity. Reconstituted solutions should be sub-aliquoted into single-use experimental volumes and frozen at -80°C.
What is the structural difference between Tesamorelin and native GHRH(1-44)?
Tesamorelin features a trans-3-hexenoic acid group attached to the N-terminal tyrosine residue of the 44-amino acid GHRH sequence. This modification increases resistance to DPP-IV enzymatic cleavage while maintaining selective GHRH receptor affinity.
Where are PX1 Research peptides manufactured and tested?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and undergo independent third-party analytical verification in ISO 17025 accredited laboratories.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.